Cargando…
Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale
AIM: To compare the outcomes between laparoscopic Nissen fundoplication (LNF) and proton pump inhibitors (PPIs) therapy in patients with laryngopharyngeal reflux (LPR) and type I hiatal hernia diagnosed by oropharyngeal pH-monitoring and symptom-scale assessment. METHODS: From February 2014 to Janua...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442091/ https://www.ncbi.nlm.nih.gov/pubmed/28596691 http://dx.doi.org/10.3748/wjg.v23.i19.3546 |
_version_ | 1783238333783080960 |
---|---|
author | Zhang, Chao Hu, Zhi-Wei Yan, Chao Wu, Qiong Wu, Ji-Min Du, Xing Liu, Dian-Gang Luo, Tao Li, Fei Wang, Zhong-Gao |
author_facet | Zhang, Chao Hu, Zhi-Wei Yan, Chao Wu, Qiong Wu, Ji-Min Du, Xing Liu, Dian-Gang Luo, Tao Li, Fei Wang, Zhong-Gao |
author_sort | Zhang, Chao |
collection | PubMed |
description | AIM: To compare the outcomes between laparoscopic Nissen fundoplication (LNF) and proton pump inhibitors (PPIs) therapy in patients with laryngopharyngeal reflux (LPR) and type I hiatal hernia diagnosed by oropharyngeal pH-monitoring and symptom-scale assessment. METHODS: From February 2014 to January 2015, 70 patients who were diagnosed with LPR and type I hiatal hernia and referred for symptomatic assessment, oropharyngeal pH-monitoring, manometry, and gastrointestinal endoscopy were enrolled in this study. All of the patients met the inclusion criteria. All of the patients underwent LNF or PPIs administration, and completed a 2-year follow-up. Patients’ baseline characteristics and primary outcome measures, including comprehensive and single symptoms of LPR, PPIs independence, and satisfaction, and postoperative complications were assessed. The outcomes of LNF and PPIs therapy were analyzed and compared. RESULTS: There were 31 patients in the LNF group and 39 patients in the PPI group. Fifty-three patients (25 in the LNF group and 28 in the PPI group) completed reviews and follow-up. Oropharyngeal pH-monitoring parameters were all abnormal with high acid exposure, a large amount of reflux, and a high Ryan score, associated reflux symptom index (RSI) score. There was a significant improvement in the RSI and LPR symptom scores after the 2-year follow-up in both groups (P < 0.05), as well as typical symptoms of gastroesophageal reflux disease. Improvement in the RSI (P < 0.005) and symptom scores of cough (P = 0.032), mucus (P = 0.011), and throat clearing (P = 0.022) was significantly superior in the LNF group to that in the PPI group. After LNF and PPIs therapy, 13 and 53 patients achieved independence from PPIs therapy (LNF: 44.0% vs PPI: 7.14%, P < 0.001) during follow-up, respectively. Patients in the LNF group were more satisfied with their quality of life than those in the PPI group (LNF: 62.49 ± 28.68 vs PPI: 44.36 ± 32.77, P = 0.004). Body mass index was significantly lower in the LNF group than in the PPI group (LNF: 22.2 ± 3.1 kg/m(2) vs PPI: 25.1 ± 2.9 kg/m(2), P = 0.001). CONCLUSION: Diagnosis of LPR should be assessed with oropharyngeal pH-monitoring, manometry, and the symptom-scale. LNF achieves better improvement than PPIs for LPR with type I hiatal hernia. |
format | Online Article Text |
id | pubmed-5442091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-54420912017-06-08 Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale Zhang, Chao Hu, Zhi-Wei Yan, Chao Wu, Qiong Wu, Ji-Min Du, Xing Liu, Dian-Gang Luo, Tao Li, Fei Wang, Zhong-Gao World J Gastroenterol Prospective Study AIM: To compare the outcomes between laparoscopic Nissen fundoplication (LNF) and proton pump inhibitors (PPIs) therapy in patients with laryngopharyngeal reflux (LPR) and type I hiatal hernia diagnosed by oropharyngeal pH-monitoring and symptom-scale assessment. METHODS: From February 2014 to January 2015, 70 patients who were diagnosed with LPR and type I hiatal hernia and referred for symptomatic assessment, oropharyngeal pH-monitoring, manometry, and gastrointestinal endoscopy were enrolled in this study. All of the patients met the inclusion criteria. All of the patients underwent LNF or PPIs administration, and completed a 2-year follow-up. Patients’ baseline characteristics and primary outcome measures, including comprehensive and single symptoms of LPR, PPIs independence, and satisfaction, and postoperative complications were assessed. The outcomes of LNF and PPIs therapy were analyzed and compared. RESULTS: There were 31 patients in the LNF group and 39 patients in the PPI group. Fifty-three patients (25 in the LNF group and 28 in the PPI group) completed reviews and follow-up. Oropharyngeal pH-monitoring parameters were all abnormal with high acid exposure, a large amount of reflux, and a high Ryan score, associated reflux symptom index (RSI) score. There was a significant improvement in the RSI and LPR symptom scores after the 2-year follow-up in both groups (P < 0.05), as well as typical symptoms of gastroesophageal reflux disease. Improvement in the RSI (P < 0.005) and symptom scores of cough (P = 0.032), mucus (P = 0.011), and throat clearing (P = 0.022) was significantly superior in the LNF group to that in the PPI group. After LNF and PPIs therapy, 13 and 53 patients achieved independence from PPIs therapy (LNF: 44.0% vs PPI: 7.14%, P < 0.001) during follow-up, respectively. Patients in the LNF group were more satisfied with their quality of life than those in the PPI group (LNF: 62.49 ± 28.68 vs PPI: 44.36 ± 32.77, P = 0.004). Body mass index was significantly lower in the LNF group than in the PPI group (LNF: 22.2 ± 3.1 kg/m(2) vs PPI: 25.1 ± 2.9 kg/m(2), P = 0.001). CONCLUSION: Diagnosis of LPR should be assessed with oropharyngeal pH-monitoring, manometry, and the symptom-scale. LNF achieves better improvement than PPIs for LPR with type I hiatal hernia. Baishideng Publishing Group Inc 2017-05-21 2017-05-21 /pmc/articles/PMC5442091/ /pubmed/28596691 http://dx.doi.org/10.3748/wjg.v23.i19.3546 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Prospective Study Zhang, Chao Hu, Zhi-Wei Yan, Chao Wu, Qiong Wu, Ji-Min Du, Xing Liu, Dian-Gang Luo, Tao Li, Fei Wang, Zhong-Gao Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale |
title | Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale |
title_full | Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale |
title_fullStr | Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale |
title_full_unstemmed | Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale |
title_short | Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale |
title_sort | nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on ph-monitoring and symptom-scale |
topic | Prospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442091/ https://www.ncbi.nlm.nih.gov/pubmed/28596691 http://dx.doi.org/10.3748/wjg.v23.i19.3546 |
work_keys_str_mv | AT zhangchao nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT huzhiwei nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT yanchao nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT wuqiong nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT wujimin nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT duxing nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT liudiangang nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT luotao nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT lifei nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale AT wangzhonggao nissenfundoplicationvsprotonpumpinhibitorsforlaryngopharyngealrefluxbasedonphmonitoringandsymptomscale |